Cel Sci Corporation (CVM)

[GD]

Call Options opened today up to 60 cross all option chain, this implys
street is expecting MK trial potential success and fair value up to
60, my base is trial pass the test with 10% to 15%, stock worth 50 to 60,
anything above 20%, 85 to 95, if Geert's expectation of to repeat PII
results of 33%, 100+, IMO. From Geert's tweet, My read, Geert is
telegraphing to us, MK data is between 10% to 33%, more likely at high
end, I bought 300 MAR calls back today, just to be safe, but I am
90% sure TLD come out before FEB 19, full data at ASCO in June.
Tomorrow is end of month, shorts may try to force CVM down 1 or 2
for window dressing, I expect next Monday is whole new ball game, IMO.

This comment imply data PR is very close, IMO.
Geert Kersten
@GeertKersten1
Replying to
@biggercapital
I want to ski with you. It is my favorite sport, yet, so close to the end of our Phase 3 study I cannot risk getting sick. That would be simply stupid. Enjoy.

This comment imply OS primary end point top limit is PII OS, 33%, IMO.
Geert Kersten
@GeertKersten1
Replying to
@Kevin_W81
$CVM We need help every day because the idea for our cancer drug is to increase the “intent to cure” success rate, using cancer immunotherapy BEFORE surgery, etc. No one has ever done that before. If we only replicate our Phase 2 results, we will save countless lives. We believe!